131 related articles for article (PubMed ID: 35696251)
21. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
22. A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer.
Bennett G; Sadlier D; Doran PP; Macmathuna P; Murray DW
BMC Cancer; 2011 Feb; 11():50. PubMed ID: 21284875
[TBL] [Abstract][Full Text] [Related]
23. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
Suzuki M; Yokobori T; Gombodorj N; Yashiro M; Turtoi A; Handa T; Ogata K; Oyama T; Shirabe K; Kuwano H
J Surg Oncol; 2018 Nov; 118(6):966-974. PubMed ID: 30260476
[TBL] [Abstract][Full Text] [Related]
24. An integrative approach identified genes associated with drug response in gastric cancer.
Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK
Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747
[TBL] [Abstract][Full Text] [Related]
25. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
26. WD40 repeat-containing 62 overexpression as a novel indicator of poor prognosis for human gastric cancer.
Zeng S; Tao Y; Huang J; Zhang S; Shen L; Yang H; Pei H; Zhong M; Zhang G; Liu T; Zhou M; Shen H
Eur J Cancer; 2013 Nov; 49(17):3752-62. PubMed ID: 23920402
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
28. Significant association of DIRC1 overexpression with tumor progression and poor prognosis in gastric cancer.
Li Z; Yang AJ; Wei FM; Zhao XH; Shao ZY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8682-8689. PubMed ID: 30575946
[TBL] [Abstract][Full Text] [Related]
29.
Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
Habib R; Akhtar J; Taqi M; Yu C; Zhang C
Oncol Rep; 2015 Aug; 34(2):859-67. PubMed ID: 26043753
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
32. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis.
Zhang Y; Wu X; Zhang C; Wang J; Fei G; Di X; Lu X; Feng L; Cheng S; Yang A
J Pathol; 2020 Jun; 251(2):135-146. PubMed ID: 32207854
[TBL] [Abstract][Full Text] [Related]
33. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m
Shen W; Zhu M; Wang Q; Zhou X; Wang J; Wang T; Zhang J
RNA Biol; 2022 Jan; 19(1):751-763. PubMed ID: 35638109
[TBL] [Abstract][Full Text] [Related]
34. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
35. Gastric cancer and genomics: review of literature.
Onoyama T; Ishikawa S; Isomoto H
J Gastroenterol; 2022 Aug; 57(8):505-516. PubMed ID: 35751736
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.
Mukai S; Oue N; Oshima T; Imai T; Sekino Y; Honma R; Sakamoto N; Sentani K; Kuniyasu H; Egi H; Tanabe K; Yoshida K; Ohdan H; Yasui W
J Pathol; 2017 Sep; 243(1):100-110. PubMed ID: 28671736
[TBL] [Abstract][Full Text] [Related]
37. Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer.
Hu Q; Masuda T; Koike K; Sato K; Tobo T; Kuramitsu S; Kitagawa A; Fujii A; Noda M; Tsuruda Y; Otsu H; Kuroda Y; Ito S; Oki E; Mimori K
Sci Rep; 2021 Sep; 11(1):19178. PubMed ID: 34584127
[TBL] [Abstract][Full Text] [Related]
38. Integrative genomic and functional profiling of the pancreatic cancer genome.
Shain AH; Salari K; Giacomini CP; Pollack JR
BMC Genomics; 2013 Sep; 14():624. PubMed ID: 24041470
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
40. NIMA related kinase 2 promotes gastric cancer cell proliferation
Fan WD; Chen T; Liu PJ
World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]